Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeekBreaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek
  • Home
  • Nation
  • Politics
  • Economy
  • Sports
  • Entertainment
  • International
  • Technology
  • Auto News
Reading: IndusInd Bank Stock Plummets 25% Due to Derivatives Accounting Woes
Share
Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeekBreaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek
  • Home
  • Nation
  • Politics
  • Economy
  • Sports
  • Entertainment
  • International
  • Technology
  • Auto News
© 2024 All Rights Reserved | Powered by India News Week
Trending Now: Stay updated with the latest breaking news from India and around the world
Derivatives accounting hit: IndusInd Bank’s stock loses about a quarter of its value in a single day
Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek > Economy > IndusInd Bank Stock Plummets 25% Due to Derivatives Accounting Woes
Economy

IndusInd Bank Stock Plummets 25% Due to Derivatives Accounting Woes

Economy Desk By Economy Desk March 11, 2025 2 Min Read
Share
SHARE

IndusInd Bank’s stock witnessed a sharp decline of 27.17% in a single day, resulting from various negative factors such as discrepancies in the accounting of derivatives portfolio, a shorter tenure approved for the CEO by the regulator, and concerns regarding the asset quality of the microfinance portfolio.

The estimated impact of around ₹1,500 crore on the balance sheet due to accounting discrepancies in the derivatives portfolio led to the significant drop in the bank’s stock price. Despite this, the promoters of the bank, Indusind International Holdings Ltd (IIHL) and Indusind Ltd, reassured shareholders not to panic and expressed their commitment to the institution. They even indicated their willingness to increase their stake in the bank.

Ashok Hinduja, Chairman of IIHL, stated that the estimated impact was manageable and that the management was working to address the issue. He emphasized the long-term growth story of the bank and the promoters’ unwavering support. Hinduja also mentioned that the promoters have received in-principle approval from the RBI to increase their stake in the bank from 15% to 26%.

In response to the internal review findings, which revealed discrepancies in the derivative portfolio accounting, the bank is working on validating these findings through an external agency. The bank’s profitability and capital adequacy are strong enough to absorb this one-time impact.

Furthermore, the RBI extended the CEO’s tenure for a year despite the initial three-year re-appointment approval by the bank’s board. The promoters are prepared to inject capital into the bank once they receive final approval from the regulator.

Overall, despite the challenges faced by IndusInd Bank, the promoters remain confident in the institution’s resilience and are committed to supporting its growth and stability in the long run.

TAGGED:Economy NewsNews
Share This Article
Twitter Copy Link
Previous Article Ninja Swirl by Creami Soft Serve Machine Review: Joy in Every Cup Savor Every Scoop: A Delightful Review of the Ninja Swirl Soft Serve Machine
Next Article AP set to attract mega tourism investments with new land allotment policy AP’s New Land Allotment Policy to Drive Major Tourism Investments
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Latest News

Raj Waqf Urges Jaipur Mosques to Install CCTVs Amid Rising Demolition Fears

July 6, 2026

Carlos Queiroz Departs as Ghana’s Coach After World Cup Exit

July 6, 2026

Case Filed Against 8 Individuals After Mosque Demolition in Sambhal Due to ‘I Love Muhammad’ Posters

July 6, 2026

Anthony Elanga and Yoane Wissa Aim to Shine for Newcastle Post-World Cup

July 6, 2026

TINA Myth Debunked: Exploring Alternatives in AI and Technology-Driven Politics

July 6, 2026
Sensex today | Stock Market Live Updates: Stocks in Focus today: Supriya Lifescience; Rubicon Research; Fortis Healthcare; Fermenta Biotech

Stock Market Today: Key Updates on Supriya Lifescience, Rubicon Research, Fortis Healthcare, and Fermenta Biotech

July 6, 2026

You Might Also Like

Broker’s call: Fortis Healthcare (Buy)
Economy

Experts Recommend Buying Fortis Healthcare Amid Promising Growth Potential

2 Min Read
SEBI sets 30-day deadline for NFO deployment
Economy

SEBI mandates 30-day deadline for NFO launch

2 Min Read
Kiran Desai is a favorite and US authors make a strong showing on the Booker Prize shortlist
Nation

Kiran Desai Shines as US Authors Stand Out on Booker Prize Shortlist

3 Min Read
Haryana IPS 'suicide' case: A video, another death, and a 'sacrifice' - what ASI said in his last video
Nation

Tragic Haryana IPS Case: ASI’s Last Video Reveals Dark Secrets and Sacrifice

4 Min Read

About IndiaNewsWeek

IndiaNewsWeek is your trusted source for breaking news, in-depth analysis, and comprehensive coverage of India and the world. We deliver accurate, timely reporting across politics, economy, sports, entertainment, and technology.

contact@indianewsweek.com

Quick Links

  • Nation
  • Politics
  • Economy
  • International
  • Sports
  • Entertainment

More Sections

  • Technology
  • Auto News
  • Education
  • About Us
  • Contact
  • Privacy Policy

Stay Connected

Follow us on social media for the latest updates and breaking news.

Facebook
X (Twitter)
YouTube
Follow US
© 2026 IndiaNewsWeek. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?